Clinical Trial Update: Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99

View source ↗

Summary

Expanded Access Trial of belimumab for rheumatoid arthritis is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Human Genome Sciences Inc., a GSK Company | Conditions: Rheumatoid Arthritis | Status: NO_LONGER_AVAILABLE